CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Fine, Kaplan and Black, R.P.C. 宣佈,若您於 2009 年 5 月 1 日至 2019 年 12 月 31 日期間曾在美國支付或償付若干處方仿製藥費用,現可提交集體訴訟和解申索表格

Neutral
AI Analysis

Summary

Legal notice regarding a $533 million class action settlement for generic drug antitrust claims covering payments made between May 1, 2009 and December 31, 2019 in the United States.

Importance:1/10
Sentiment:
0.00
legalsettlementgeneric drugsantitrustclass action
Related Companies

Read the original article

Published by PR Newswire Pharma on July 10, 2026 9:00 PM

Read Original